X0306 4 2019-09-16 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001681098 McFarlane Neil F. C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 0 1 0 0 Chief Executive Officer Common Stock 2019-09-16 4 A 0 125000 0.00 A 125000 D Stock Option (Right to Buy) 6.25 2019-09-16 4 A 0 250000 0.00 A 2029-09-15 Common Stock 250000 250000 D The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of September 16, 2020, September 16, 2021, September 16, 2022 and September 16, 2023, subject to Reporting Person's Continuous Service as of each such date. The Option shares shall vest as follows: 25% of the shares subject to the option shall vest on September 16, 2020 and an additional 1/48th of the shares subject to the option shall vest on a monthly basis thereafter over the following 36 months. /s/ Jennifer Rhodes, Attorney-in-fact 2019-09-17